Skip to main content
. 2019 Apr 15;55(4):107. doi: 10.3390/medicina55040107

Table 5.

Histopathological evaluation for nephroprotective effects of CMHE.

Treatment Groups Tubular Degeneration Tubulo-Interstitial Inflammation Tubular Necrosis
Normal Control 0 0 0
Toxic Control
(Gentamicin 100 mg/kg/day)
2 4 4
Gentamicin + CMHE 250 mg/kg/day 1 4 0
Gentamicin + CMHE 500 mg/kg/day 0 2 0

Values presented are on the basis of histopathological observations. Grade 0 = no damage, grade 1 = mild cellular degradations, grade 2 = moderate cellular degenerations, and grade 4 = severe deformities.